Addition of AEG35156 XIAP Antisense Oligonucleotide in Reinduction Chemotherapy Does Not Improve Remission Rates in Patients With Primary Refractory Acute Myeloid Leukemia in a Randomized Phase II Study
Titel:
Addition of AEG35156 XIAP Antisense Oligonucleotide in Reinduction Chemotherapy Does Not Improve Remission Rates in Patients With Primary Refractory Acute Myeloid Leukemia in a Randomized Phase II Study
Auteur:
Schimmer, Aaron D. Herr, Wolfgang Hänel, Mathias Borthakur, Gautham Frankel, Arthur Horst, Heinz-August Martin, Sonja Kassis, Jeannine Desjardins, Pierre Seiter, Karen Fiedler, Walter Noppeney, Richard Giagounidis, Aristoteles Jacob, Christine Jolivet, Jacques Tallman, Martin S. Koschmieder, Steffen